申请人:Hubler Francis
公开号:US20110039905A1
公开(公告)日:2011-02-17
The invention relates to compounds of formula (I)
wherein
R
1
represents aryl, which is unsubstituted, or mono-, di-, or tri-substituted wherein the substituents are independently selected from the group consisting of (C
1-4
)alkyl, (C
1-4
)alkoxy, halogen, and trifluoromethyl;
R
2
represents hydrogen, or —CO—R
21
;
R
21
represents (C
1-5
)alkyl, (C
1-3
)fluoroalkyl, or (C
3-6
)cycloalkyl;
m represents the integer 2, or 3;
p represents the integer 2 or 3; and
R
3
represents hydrogen, or (C
1-5
)alkyl;
and pharmaceutically acceptable salts of such compounds.
These compounds are useful as calcium channel blockers.
该发明涉及以下式(I)的化合物,其中R1代表芳基,未取代,或者单取代、双取代或三取代,其中取代基独立地选自(C1-4)烷基,(C1-4)氧烷基,卤素和三氟甲基组成的组;R2代表氢,或者—CO—R21;R21代表(C1-5)烷基,(C1-3)氟烷基或(C3-6)环烷基;m表示整数2或3;p表示整数2或3;和R3代表氢,或者(C1-5)烷基;以及这些化合物的药用盐。这些化合物可用作钙通道阻滞剂。